First COVID-19 case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 14 09 2020
revised: 29 09 2020
accepted: 30 09 2020
pubmed: 10 10 2020
medline: 15 1 2021
entrez: 9 10 2020
Statut: ppublish

Résumé

Since its first discovery in December 2019 in Wuhan, China, COVID-19, caused by the novel coronavirus SARS-CoV-2, has spread rapidly worldwide. While African countries were relatively spared initially, the initial low incidence of COVID-19 cases was not sustained for long due to continuing travel links between China, Europe and Africa. In preparation, Zambia had applied a multisectoral national epidemic disease surveillance and response system resulting in the identification of the first case within 48 h of the individual entering the country by air travel from a trip to France. Contact tracing showed that SARS-CoV-2 infection was contained within the patient's household, with no further spread to attending health care workers or community members. Phylogenomic analysis of the patient's SARS-CoV-2 strain showed that it belonged to lineage B.1.1., sharing the last common ancestor with SARS-CoV-2 strains recovered from South Africa. At the African continental level, our analysis showed that B.1 and B.1.1 lineages appear to be predominant in Africa. Whole genome sequence analysis should be part of all surveillance and case detection activities in order to monitor the origin and evolution of SARS-CoV-2 lineages across Africa.

Identifiants

pubmed: 33035675
pii: S1201-9712(20)32196-2
doi: 10.1016/j.ijid.2020.09.1480
pmc: PMC7537667
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-459

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Emerg Infect Dis. 2009 Oct;15(10):1598-602
pubmed: 19861052
BMC Health Serv Res. 2020 Jan 13;20(1):35
pubmed: 31931793
JAMA. 2020 May 26;323(20):2089-2090
pubmed: 32320008
Bull World Health Organ. 2020 Jul 1;98(7):495-504
pubmed: 32742035
J Infect Dis. 2018 Nov 22;218(suppl_5):S312-S317
pubmed: 29889270
Int J Clin Pract. 2020 Aug;74(8):e13525
pubmed: 32374903
Emerg Infect Dis. 2019 Aug;25(8):1577-1580
pubmed: 31146800
Int J Infect Dis. 2020 Apr;93:233-236
pubmed: 32119980
J Infect Dis. 2012 Dec 15;206 Suppl 1:S173-7
pubmed: 23169966
J Infect Dis. 2015 Oct 1;212 Suppl 2:S101-8
pubmed: 25786916
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831
pubmed: 32329222
J Infect Dis. 2018 Oct 15;218(suppl_3):S181-S183
pubmed: 30215738
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813
pubmed: 32279441
J Gen Virol. 2011 Jun;92(Pt 6):1416-1427
pubmed: 21367986
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
Emerg Infect Dis. 2020 Oct;26(10):2411-2415
pubmed: 32614767
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Mol Biol Evol. 2013 May;30(5):1188-95
pubmed: 23418397

Auteurs

Edgar Simulundu (E)

Macha Research Trust, Choma, Zambia; University of Zambia, School of Veterinary Medicine, Lusaka, Zambia. Electronic address: edgar.simulundu@macharesearch.org.

Francis Mupeta (F)

Ministry of Health, Lusaka, Zambia. Electronic address: mupetaf@yahoo.co.uk.

Pascalina Chanda-Kapata (P)

Ministry of Health, Lusaka, Zambia. Electronic address: pascykapata@gmail.com.

Ngonda Saasa (N)

University of Zambia, School of Veterinary Medicine, Lusaka, Zambia. Electronic address: nsaasa@gmail.com.

Katendi Changula (K)

University of Zambia, School of Veterinary Medicine, Lusaka, Zambia. Electronic address: ckchangula@unza.zm.

Walter Muleya (W)

University of Zambia, School of Veterinary Medicine, Lusaka, Zambia. Electronic address: muleyawalter@gmail.com.

Simbarashe Chitanga (S)

University of Zambia, School of Health Sciences, Lusaka, Zambia; Hokkaido University, Research Centre for Zoonosis Control, Sapporo, Japan. Electronic address: schitanga@gmail.com.

Miniva Mwanza (M)

Ministry of Health, Lusaka, Zambia. Electronic address: mwanza93miniva@gmail.com.

Paul Simusika (P)

Ministry of Health, Lusaka, Zambia. Electronic address: psimusika@yahoo.co.uk.

Herman Chambaro (H)

Hokkaido University, Research Centre for Zoonosis Control, Sapporo, Japan. Electronic address: hermcham@gmail.com.

Benjamin Mubemba (B)

Copperbelt University, School of Natural Resources, Kitwe, Zambia. Electronic address: mubembab85@yahoo.co.uk.

Masahiro Kajihara (M)

Hokkaido University, Research Centre for Zoonosis Control, Sapporo, Japan. Electronic address: kajihara@czc.hokudai.ac.jp.

Duncan Chanda (D)

Ministry of Health, Lusaka, Zambia. Electronic address: duncanchanda@gmail.com.

Lloyd Mulenga (L)

Ministry of Health, Lusaka, Zambia. Electronic address: lbmulenga@yahoo.com.

Sombo Fwoloshi (S)

Ministry of Health, Lusaka, Zambia. Electronic address: sombofwoloshi@gmail.com.

Aaron Lunda Shibemba (AL)

Ministry of Health, Lusaka, Zambia. Electronic address: shibemba@yahoo.com.

Fred Kapaya (F)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: fkapaya2007@gmail.com.

Paul Zulu (P)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: drzulupm@gmail.com.

Kunda Musonda (K)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: kundagk@yahoo.com.

Mwaka Monze (M)

Ministry of Health, Lusaka, Zambia. Electronic address: mwakamonze@hotmail.com.

Nyambe Sinyange (N)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: bsinyange@gmail.com.

Mazyanga L Mazaba (ML)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: mazyanga.mazaba@znphi.co.zm.

Muzala Kapin'a (M)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: mkapina100@gmail.com.

Peter J Chipimo (PJ)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: peterjchipimo@gmail.com.

Raymond Hamoonga (R)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: raymondhamoonga1@gmail.com.

Davie Simwaba (D)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: simwaba74@gmail.com.

William Ngosa (W)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: ngosawilliam@gmail.com.

Albertina N Morales (AN)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: albertina.ngomah@gmail.com.

Nkomba Kayeyi (N)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: nkayeyi@popcouncil.org.

John Tembo (J)

HerpeZ and UNZA-UCLMS Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: john.tembo@gmail.com.

Mathew Bates (M)

HerpeZ and UNZA-UCLMS Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: matthewxbates@gmail.com.

Yasuko Orba (Y)

Hokkaido University, Research Centre for Zoonosis Control, Sapporo, Japan. Electronic address: orbay@czc.hokudai.ac.jp.

Hirofumi Sawa (H)

University of Zambia, School of Veterinary Medicine, Lusaka, Zambia. Electronic address: h-sawa@czc.hokudai.ac.jp.

Ayato Takada (A)

University of Zambia, School of Veterinary Medicine, Lusaka, Zambia. Electronic address: atakada@czc.hokudai.ac.jp.

King S Nalubamba (KS)

University of Zambia, School of Veterinary Medicine, Lusaka, Zambia. Electronic address: king.nalubamba@unza.zm.

Kennedy Malama (K)

Ministry of Health, Lusaka, Zambia. Electronic address: malamakennedy@gmail.com.

Victor Mukonka (V)

Division of Infection and Immunity, CCM, University College London, London, United Kingdom. Electronic address: victor.mukonka@znphi.co.zm.

Alimuddin Zumla (A)

Division of Infection and Immunity, CCM, University College London, London, United Kingdom; University College London Hospitals NHS Foundation Trust NIHR Biomedical Research Centre, London, United Kingdom. Electronic address: a.i.zumla@gmail.com.

Nathan Kapata (N)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: nkapata@gmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH